“…An activating mutation of the FGFR3 (fibroblast growth factor receptor 3) causes major growth inhibition of the extremities and thus extreme short stature in achondroplasia. Growth in achondroplasia has been described by several authors (Murdoch et al, ; Nehme, Riseborough, & Tredwell, ; Wynne‐Davies, Walsh, & Gormley, ) and growth curves have been published from the United States (Hoover‐Fong, McGready, Schulze, Alade, & Scott, ; Hoover‐Fong, McGready, Schulze, Barnes, & Scott, ; Hoover‐Fong, Schulze, McGready, Barnes, & Scott, ; Horton, Rotter, Rimoin, Scott, & Hall, ), Japan (Tachibana, Suwa, Nishiyama, & Matsuda, ), Argentina (Del Pino, Fano, & Lejarraga, ), and Australia (Tofts, Das, Collins, & Burton, ). However, there are no recent European growth curves.…”